Defining the risk factors affecting the prognosis of patients with acute coronary syndrome (ACS) has been a challenge. Many individual biomarkers and risk scores that predict outcomes during different periods following ACS have been proposed. This review evaluates known outcome predictors supported by clinical data in light of the development of new treatment strategies for ACS patients during the last three decades.

Department of Cardiology 3rd Faculty of Medicine Charles University University Hospital Královské Vinohrady 100 34 Prague Czech Republic

Zobrazit více v PubMed

De Lemos J.A., Orrow D.A., Bentley J.H., Omland T.O., Sabatine M.S., McCabe C.H., Hall C., Cannon C.P., Braunwald E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndrome. N. Engl. J. Med. 2001;345:1014–1021. doi: 10.1056/NEJMoa011053. PubMed DOI

Weber M., Bazzino O., Estrada J.L.N., Fuselli J.J., Botto F., De Arenaza D.P., Möllmann H., Nef H.N., Elsässer A., Hamm C.W. N-Terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. J. Am. Coll. Cardiol. 2008;51:1188–1195. doi: 10.1016/j.jacc.2007.11.054. PubMed DOI

Collet J.-P., Thiele H., Barbato E., Barthélémy O., Bauersachs J., Bhatt D.L., Dendale P., Dorobantu M., Edvardsen T., Folliguet T., et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur. Heart J. 2021;42:1289–1367. doi: 10.1093/eurheartj/ehaa575. PubMed DOI

McNamara R.L., Kennedy K.F., Cohen D.J., Diercks D.B., Moscucci M., Ramee S., Wang T.Y., Connolly T., Spertus J.A. Predicting in-hospital mortality in patients with acute myocardial infarction. J. Am. Coll. Cardiol. 2016;68:626–635. doi: 10.1016/j.jacc.2016.05.049. PubMed DOI

Thielmann M., Massoudy P., Neuhäuser M., Tsagakis K., Marggraf G., Kamler M., Mann K., Erbel R., Jakob H. Prognostic value of preoperative cardiac troponin I in patients undergoing emergency coronary artery bypass surgery with non-ST-elevation or ST-elevation acute coronary syndromes. Circulation. 2006;114((Suppl. 1)):I-448. doi: 10.1161/CIRCULATIONAHA.105.001057. PubMed DOI

Myint P.K., Kwok C.S., Bachmann M.O., Stirling S., Shepstone L., Zaman M.J.S. Prognostic value of troponins in acute coronary syndrome depends upon patient age. Heart. 2014;100:1583–1590. doi: 10.1136/heartjnl-2014-305533. PubMed DOI

Bardají A., Bonet G., Carrasquer A., Hoyo M.G.-D., Domínguez F., Sanchez R., Boqué C., Cediel G. Prognostic implications of detectable cardiac troponin I below the 99th percentile in patients admitted to an emergency department without acute coronary syndrome. Clin. Chem. Lab. Med. 2018;56:1954–1961. doi: 10.1515/cclm-2017-1140. PubMed DOI

Than M.P., Aldous S.J., Troughton R.W., Pemberton C.J., Richards A.M., Frampton C.M., Florkowski C.M., George P.M., Bailey S., Young J.M., et al. Detectable high-sensitivity cardiac troponin within the population reference interval conveys high 5-year cardiovascular risk: An observational study. Clin. Chem. 2018;64:1044–1053. doi: 10.1373/clinchem.2017.285700. PubMed DOI

Lindahl B., Diderholm E., Lagerqvist B., Venge P., Wallentin L. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: A FRISC II substudy. J. Am. Coll. Cardiol. 2001;38:979–986. doi: 10.1016/S0735-1097(01)01501-7. PubMed DOI

Forte L., Cimmino G., Loffredo F., De Palma R., Abbate G., Calabrò P., Ingrosso D., Galletti P., Carangio C., Casillo B., et al. C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes. Int. J. Cardiol. 2011;152:7–12. doi: 10.1016/j.ijcard.2011.05.062. PubMed DOI

Griselli M., Herbert J., Hutchinson W., Taylor K., Sohail M., Krausz T., Pepys M. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J. Exp. Med. 1999;190:1733–1740. doi: 10.1084/jem.190.12.1733. PubMed DOI PMC

He L.-P., Tang X.-Y., Ling W.-H., Chen W.-Q., Chen Y.-M. Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: A meta-analysis of longitudinal studies. Heart 2. 2010;96:339–346. doi: 10.1136/hrt.2009.174912. PubMed DOI

Kacprzak M., Zielinska M. Prognostic value of myeloperoxidase concentration in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Int. J. Cardiol. 2016;223:452–457. doi: 10.1016/j.ijcard.2016.07.258. PubMed DOI

Brennan M.-L., Penn M.S., Van Lente F., Nambi V., Shishehbor M.H., Aviles R.J., Goormastic M., Pepoy M.L., McErlean E.S., Topol E., et al. Prognostic value of myeloperoxidase in patients with chest pain. N. Engl. J. Med. 2003;349:1595–1604. doi: 10.1056/NEJMoa035003. PubMed DOI

Kaya M.G., Yalcin R., Okyay K., Poyraz F., Bayraktar N., Pasaoglu H., Boyaci B., Cengel A. Potential Role of Plasma Myeloperoxidase Level in Predicting Long-Term Outcome of Acute Myocardial Infarction. Tex. Heart Inst. J. 2012;39:500. PubMed PMC

Baldus S., Heeschen C., Meinertz T., Zeiher A.M., Eiserich J.P., Münzel T., Simoons M.L., Hamm C.W. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation. 2003;108:1440–1445. doi: 10.1161/01.CIR.0000090690.67322.51. PubMed DOI

Mocatta T.J., Pilbrow A., Cameron V.A., Senthilmohan R., Frampton C.M., Richards A.M., Winterbourn C.C. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J. Am. Coll. Cardiol. 2007;49:1993–2000. doi: 10.1016/j.jacc.2007.02.040. PubMed DOI

Teringova E., Kozel M., Knot J., Kocka V., Benesova K., Tousek P. Relationship between TRAIL and left ventricular ejection fraction in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. BioMed Res. Int. 2018;2018:1–8. doi: 10.1155/2018/3709084. PubMed DOI PMC

Sabatine M.S., Morrow D.A., de Lemos J.A., Gibson C.M., Murphy S.A., Rifai N., McCabe C., Antman E.M., Cannon C.P., Braunwald E. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: Simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation. 2002;105:1760–1763. doi: 10.1161/01.CIR.0000015464.18023.0A. PubMed DOI

Califf R.M., Mark D.B., Harrell F.E., Hlatky M.A., Lee K.L., Rosati R.A., Pryor D.B. Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease. J. Am. Coll. Cardiol. 1988;11:20–26. doi: 10.1016/0735-1097(88)90160-X. PubMed DOI

Braunwald E. Unstable angina: A classification. Circulation. 1989;80:410–414. doi: 10.1161/01.CIR.80.2.410. PubMed DOI

Calvin J.E., Klein L.W., Vandenberg B.J., Meyer P., Condon J.V., Snell R.J., Ramirez-Morgen L.M., Parrillo J.E. Risk stratification in unstable angina: Prospective validation of the Braunwald classification. JAMA. 1995;273:136–141. doi: 10.1001/jama.1995.03520260058033. PubMed DOI

Lee K.L., Woodlief L.H., Topol E.J., Weaver W.D., Betriu A., Col J., Simoons M., Aylward P., Van De Werf F., Califf R.M. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: Results from an international trial of 41,021 patients. Circulation. 1995;91:1659–1668. doi: 10.1161/01.CIR.91.6.1659. PubMed DOI

Cannon C.P., McCabe C.H., Stone P.H., Rogers W.J., Schactman M., Thompson B.W., Pearce D.J., Diver D.J., Kells C., Feldman T., et al. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: Results of the TIMI III registry ECG ancillary study. J. Am. Coll. Cardiol. 1997;30:133–140. doi: 10.1016/S0735-1097(97)00160-5. PubMed DOI

Sharis P.J., Cannon C.P., Rogers W.J., McCabe C., Murphy S., Gibson C.M., Stone P.H., Braunwald E. Predictors of mortality, coronary angiography, and revascularization in unstable angina pectoris and acute non-ST elevation myocardial infarction (the TIMI III registry) Am. J. Cardiol. 2002;90:1154–1156. doi: 10.1016/S0002-9149(02)02788-1. PubMed DOI

Antman E.M., Cohen M., Bernink P.J.L.M., McCabe C.H., Horacek T., Papuchis G., Mautner B., Corbalan R., Radley D., Braunwald E. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000;284:835–842. doi: 10.1001/jama.284.7.835. PubMed DOI

Morrow D.A., Antman E.M., Charlesworth A., Cairns R., Murphy S.A., de Lemos J.A., Giugliano R.P., McCabe C.H., Braunwald E. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium Early II trial substudy. Circulation. 2000;102:2031–2037. doi: 10.1161/01.CIR.102.17.2031. PubMed DOI

Tang E.W., Wong C.-K., Herbison G.P. Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am. Heart J. 2007;153:29–35. doi: 10.1016/j.ahj.2006.10.004. PubMed DOI

Boersma E., Pieper K.S., Steyerberg E.W., Wilcox R.G., Chang W.-C., Lee K.L., Akkerhuis K.M., Harrington R.A., Deckers J.W., Armstrong P.W., et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: Results from an international trial of 9461 patients. Circulation. 2000;101:2557–2567. doi: 10.1161/01.CIR.101.22.2557. PubMed DOI

Addala S., Grines C.L., Dixon S.R., Stone G.W., Boura J.A., Ochoa A.B., Pellizzon G., O’Neill W.W., Kahn J.K. Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score) Am. J. Cardiol. 2004;93:629–632. doi: 10.1016/j.amjcard.2003.11.036. PubMed DOI

De Luca G., Suryapranata H., Hof A.W.V., De Boer M.-J., Hoorntje J.C., Dambrink J.-H.E., Gosselink A.M., Ottervanger J.P., Zijlstra F. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: Implications for early discharge. Circulation. 2004;109:2737–2743. doi: 10.1161/01.CIR.0000131765.73959.87. PubMed DOI

Halkin A., Singh M., Nikolsky E., Grines C.L., Tcheng J.E., Garcia E., Cox D.A., Turco M., Stuckey T.D., Na Y., et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: The CADILLAC risk score. J. Am. Coll. Cardiol. 2005;45:1397–1405. doi: 10.1016/j.jacc.2005.01.041. PubMed DOI

Palmerini T., Genereux P., Caixeta A., Cristea E., Lansky A., Mehran R., Della Riva D., Fahy M., Xu K., Stone G.W. A new score for risk stratification of patients with acute coronary syndromes undergoing percutaneous coronary intervention: The ACUITY-PCI (Acute Catheterization and Urgent Intervention Triage Strategy-Percutaneous Coronary Intervention) risk score. JACC Cardiovasc. Interv. 2012;5:1108–1116. doi: 10.1016/j.jcin.2012.07.011. PubMed DOI

Fox K.A.A., Fitzgerald G., Puymirat E., Huang W., Carruthers K.F., Simon T., Coste P., Monsegu J., Steg P.G., Danchin N., et al. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score. BMJ Open. 2014;4:e004425. doi: 10.1136/bmjopen-2013-004425. PubMed DOI PMC

Eagle K.A., Lim M.J., Dabbous O.H., Pieper K.S., Goldberg R.J., Van de Werf F., Goodman S.G., Granger C.B., Steg P.G., Gore J.M., et al. A validated prediction model for all forms of acute coronary syndrome estimating the risk of 6-month postdischarge death in an international registry. JAMA. 2004;291:2727–2733. doi: 10.1001/jama.291.22.2727. PubMed DOI

Abu-Assi E., García-Acuña J.M., Peña-Gil C., González-Juanatey J.R. Validation of the GRACE risk score for predicting death within 6 months of follow-up in a contemporary cohort of patients with acute coronary syndrome. Rev. Española Cardiol. 2010;63:640–648. doi: 10.1016/S0300-8932(10)70156-1. PubMed DOI

Grines C.L., Browne K.F., Marco J., Rothbaum D., Stone G.W., O’Keefe J., Overlie P., Donohue B., Chelliah N., Timmis G.C., et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N. Engl. J. Med. 1993;328:673–679. doi: 10.1056/NEJM199303113281001. PubMed DOI

Gibbons R.J., Holmes D.R., Reeder G.S., Bailey K.R., Hopfenspirger M.R., Gersh B.J. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N. Engl. J. Med. 1993;328:685–691. doi: 10.1056/NEJM199303113281003. PubMed DOI

Zijlstra F., De Boer M.J., Hoorntje J., Reiffers S., Reiber J., Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N. Engl. J. Med. 1993;328:680–684. doi: 10.1056/NEJM199303113281002. PubMed DOI

Widimský P., Budešínský T., Voráč D., Groch L., Želízko M., Aschermann M., Branny M., Št’ásek J., Formánek P. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: Final results of the randomized national multicentre trial-PRAGUE-2. Eur. Heart J. 2003;24:94–104. doi: 10.1016/S0195-668X(02)00468-2. PubMed DOI

Gensini G.G. A more meaningful scoring system for determining the severity of coronary heart disease. Am. J. Cardiol. 1983;51:606. doi: 10.1016/S0002-9149(83)80105-2. PubMed DOI

Cakar M.A., Sahinkus S., Aydin E., Vatan M.B., Keser N., Akdemir R., Gunduz H. Relation between the GRACE score and severity of atherosclerosis in acute coronary syndrome. J. Cardiol. 2014;63:24–28. doi: 10.1016/j.jjcc.2013.06.017. PubMed DOI

Stone G.W., Cox D., Garcia E., Brodie B.R., Morice M.-C., Griffin J., Mattos L., Lansky A.J., O’Neill W.W., Grines C.L. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: Analysis from the primary angioplasty in myocardial infarction trials. Circulation. 2001;104:636–641. doi: 10.1161/hc3101.093701. PubMed DOI

De Luca G., Ernst N., Zijlstra F., Hof A.W.V., Hoorntje J.C., Dambrink J.-H.E., Gosslink A., de Boer M.-J., Suryapranata H. Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty. J. Am. Coll. Cardiol. 2004;43:1363–1367. doi: 10.1016/j.jacc.2003.11.042. PubMed DOI

De Luca G., Brener S.J., Mehran R., Lansky A.J., McLaurin B.T., Cox D.A., Cristea E., Fahy M., Stone G.W. Implications of pre-procedural TIMI flow in patients with non ST-segment elevation acute coronary syndromes undergoing percutaneous coronary revascularization: Insights from the ACUITY trial. Int. J. Cardiol. 2013;167:727–732. doi: 10.1016/j.ijcard.2012.03.058. PubMed DOI

Kim D.-W., Her S.-H., Park M.-W., Cho J.S., Kim T.-S., Kang H., Sim D.S., Hong Y.J., Kim J.H., Ahn Y., et al. Impact of postprocedural TIMI flow on long-term clinical outcomes in patients with acute myocardial infarction: Five year follow-up results in the Corea-AMI registry. Int. Heart J. 2017;58:674–685. doi: 10.1536/ihj.16-448. PubMed DOI

Ndrepepa G., Mehilli J., Schulz S., Iijima R., Keta D., Byrne R.A., Pache J., Seyfarth M., Schömig A., Kastrati A. Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syndromes. J. Am. Coll. Cardiol. 2008;52:512–517. doi: 10.1016/j.jacc.2008.05.009. PubMed DOI

Karwowski J., Poloński L., Gierlotka M., Gąsior M., Bęćkowski M., Kowalik I., Szwed H. Post-procedural TIMI flow grade 2 is not associated with improved prognosis in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary revascularization (PL-ACS registry) Cardiol. J. 2016;23:402–410. doi: 10.5603/CJ.a2016.0025. PubMed DOI

Mehta S.R., Granger C.B., Boden W.E., Steg P.G., Bassand J.-P., Faxon D.P., Afzal R., Chrolavicius S., Jolly S.S., Widimsky P., et al. Early versus delayed invasive intervention in acute coronary syndromes. N. Engl. J. Med. 2009;360:2165–2175. doi: 10.1056/NEJMoa0807986. PubMed DOI

Montalescot G., Bolognese L., Dudek D., Goldstein P., Hamm C., Tanguay J.-F., Berg J.M.T., Miller D.L., Costigan T.M., Goedicke J., et al. Pretreatment with prasugrel in non–ST-segment elevation acute coronary syndromes. N. Engl. J. Med. 2013;369:999–1010. doi: 10.1056/NEJMoa1308075. PubMed DOI

Bellemain-Appaix A., Kerneis M., O’Connor S.A., Silvain J., Cucherat M., Beygui F., Barthélémy O., Collet J.-P., Jacq L., Bernasconi F., et al. Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: A systematic review and meta-analysis. BMJ. 2013;349:g6269. doi: 10.1136/bmj.g6269. PubMed DOI PMC

Lemesle G., Laine M., Pankert M., Boueri Z., Motreff P., Paganelli F., Baumstarck K., Roch A., Kerbaul F., Puymirat E., et al. Optimal timing of intervention in NSTE-ACS without pre-treatment: The EARLY randomized trial. JACC Cardiovasc. Interv. 2020;13:907–917. doi: 10.1016/j.jcin.2020.01.231. PubMed DOI

Serruys P.W., Morice M.-C., Kappetein A.P., Colombo A., Holmes D.R., Mack M.J., Ståhle E., Feldman T.E., Brand M.V.D., Bass E.J., et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N. Engl. J. Med. 2009;360:961–972. doi: 10.1056/NEJMoa0804626. PubMed DOI

Serruys P.W., Onuma Y., Garg S., Vranckx P., De Bruyne B., Morice M.-C., Colombo A., Macaya C., Richardt G., Fajadet J., et al. 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J. Am. Coll. Cardiol. 2010;55:1093–1101. doi: 10.1016/j.jacc.2009.11.049. PubMed DOI

Palmerini T., Genereux P., Caixeta A., Cristea E., Lansky A., Mehran R., Dangas G., Lazar D., Sanchez R., Fahy M., et al. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J. Am. Coll. Cardiol. 2011;57:2389–2397. doi: 10.1016/j.jacc.2011.02.032. PubMed DOI

Garg S., Sarno G., Garcia-Garcia H.M., Girasis C., Wykrzykowska J., Dawkins K.D., Serruys P.W. A new tool for the risk stratification of patients with complex coronary artery disease the clinical SYNTAX score. Circ. Cardiovasc. Interv. 2010;3:317–326. doi: 10.1161/CIRCINTERVENTIONS.109.914051. PubMed DOI

He C., Song Y., Wang C.-S., Yao Y., Tang X.-F., Zhao X.-Y., Gao R.-L., Yang Y.-J., Xu B., Yuan J.-Q. Prognostic value of the clinical SYNTAX score on 2-year outcomes in patients with acute coronary syndrome who underwent percutaneous coronary intervention. Am. J. Cardiol. 2017;119:1493–1499. doi: 10.1016/j.amjcard.2017.02.031. PubMed DOI

Mehta S.R., Wood D.A., Storey R., Mehran R., Bainey K.R., Nguyen H., Meeks B., Di Pasquale G., López-Sendón J., Faxon D.P., et al. Complete revascularization with multivessel PCI for myocardial infarction. N. Engl. J. Med. 2019;381:1411–1421. doi: 10.1056/NEJMoa1907775. PubMed DOI

Levett J.Y., Windle S.B., Filion K.B., Cabaussel J., Eisenberg M.J. Meta-analysis of complete versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary disease. Am. J. Cardiol. 2020;135:40–49. doi: 10.1016/j.amjcard.2020.08.030. PubMed DOI

Thiele H., Akin I., Sandri M., Fuernau G., De Waha S., Meyer-Saraei R., Nordbeck P., Geisler T., Landmesser U., Skurk C., et al. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N. Engl. J. Med. 2017;377:2419–2432. doi: 10.1056/NEJMoa1710261. PubMed DOI

Thiele H., Zeymer U., Neumann F.-J., Ferenc M., Olbrich H.-G., Hausleiter J., Richardt G., Hennersdorf M., Empen K., Fuernau G., et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N. Engl. J. Med. 2012;367:1287–1296. doi: 10.1056/NEJMoa1208410. PubMed DOI

Prati F., Romagnoli E., Gatto L., La Manna A., Burzotta F., Limbruno U., Versaci F., Fabbiocchi F., Di Giorgio A., Marco V., et al. Clinical impact of suboptimal stenting and residual intrastent plaque/thrombus protrusion in patients with acute coronary syndrome. Circ. Cardiovasc. Interv. 2016;9:e003726. doi: 10.1161/CIRCINTERVENTIONS.115.003726. PubMed DOI

McPherson J., Maehara A., Weisz G., Mintz G.S., Cristea E., Mehran R., Foster M., Verheye S., Rabbani L., Xu K., et al. Residual plaque burden in patients with acute coronary syndromes after successful percutaneous coronary intervention. JACC Cardiovasc. Imaging. 2012;5((Suppl. 3)):S76–S85. doi: 10.1016/j.jcmg.2012.01.005. PubMed DOI

Costa F., van Klaveren D., James S., Heg D., Räber L., Feres F., Pilgrim T., Hong M.-K., Kim H.-S., Colombo A., et al. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: A pooled analysis of individual-patient datasets from clinical trials. Lancet. 2017;389:1025–1034. doi: 10.1016/S0140-6736(17)30397-5. PubMed DOI

Long T., Peng L., Li F., Xia K., Jing R., Liu X., Xie Q., Yang T., Zhang C. Correlations of DAPT score and PRECISE-DAPT score with the extent of coronary stenosis in acute coronary syndrome. Medicine. 2018;97:e12531. doi: 10.1097/MD.0000000000012531. PubMed DOI PMC

Castini D., Persampieri S., Sabatelli L., Erba M., Ferrante G., Valli F., Centola M., Carugo S. Utility of the HAS-BLED score for risk stratification of patients with acute coronary syndrome. Heart Vessel. 2019;34:1621–1630. doi: 10.1007/s00380-019-01405-1. PubMed DOI

Huang S.S., Chen Y.H., Chan W.L., Huang P.H., Chen J.W., Lin S.J. Usefulness of the CHADS2 score for prognostic stratification of patients with acute myocardial infarction. Am. J. Cardiol. 2014;114:1309–1314. doi: 10.1016/j.amjcard.2014.07.063. PubMed DOI

Peng H., Sun Z., Chen H., Zhang Y., Ding X., Zhao X.-Q., Li H. Usefulness of the CHA2DS2-VASc score to predict adverse outcomes in acute coronary syndrome patients without atrial fibrillation undergoing percutaneous coronary intervention. Am. J. Cardiol. 2019;124:476–484. doi: 10.1016/j.amjcard.2019.05.036. PubMed DOI

Rovelli F., De Vita C., Feruglio G.A., Lotto A., Selvini A., Tognoni G. GISSI trial: Early results and late follow-up. J. Am. Coll. Cardiol. 1987;10:33B–39B. doi: 10.1016/S0735-1097(87)80426-6. PubMed DOI

Schömig A., Neumann F.-J., Kastrati A., Schühlen H., Blasini R., Hadamitzky M., Walter H., Zitzmann-Roth E.-M., Richardt G., Alt E., et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N. Engl. J. Med. 1996;334:1084–1089. doi: 10.1056/NEJM199604253341702. PubMed DOI

Widimský P., Groch L., Zelízko M., Aschermann M., Bednář F., Suryapranata H. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE Study. Eur. Heart J. 2000;21:823–831. doi: 10.1053/euhj.1999.1993. PubMed DOI

Sousa J.E., Costa M.A., Abizaid A., Abizaid A.S., Feres F., Pinto I.M.F., Seixas A.C., Staico R., Mattos L.A., Sousa A.G.M.R., et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation. 2001;103:192–195. doi: 10.1161/01.CIR.103.2.192. PubMed DOI

Stone G.W., Rizvi A., Newman W., Mastali K., Wang J.C., Caputo R., Doostzadeh J., Cao S., Simonton C.A., Sudhir K., et al. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N. Engl. J. Med. 2010;362:1663–1674. doi: 10.1056/NEJMoa0910496. PubMed DOI

Jolly S.S., Yusuf S., Cairns J., Niemelä K., Xavier D., Widimsky P., Budaj A., Niemelä M., Valentin V., Lewis B.S., et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): A randomised, parallel group, multicentre trial. Lancet. 2011;377:1409–1420. doi: 10.1016/S0140-6736(11)60404-2. PubMed DOI

Fox K., Goodman S.G., Klein W., Brieger D., Steg P.G., Dabbous O.H., Avezum A. Management of acute coronary syndromes. Variations in practice and outcome: Findings from the Global Registry of Acute Coronary Events (GRACE) Eur. Heart J. 2002;23:1177–1189. doi: 10.1053/euhj.2001.3081. PubMed DOI

Kao Y.-T., Hsieh Y.-C., Hsu C.-Y., Huang C.-Y., Hsieh M.-H., Lin Y.-K., Yeh J.-S. Comparison of the TIMI, GRACE, PAMI and CADILLAC risk scores for prediction of long-term cardiovascular outcomes in Taiwanese diabetic patients with ST-segment elevation myocardial infarction: From the registry of the Taiwan Society of Cardiology. PLoS ONE. 2020;15:e0229186. doi: 10.1371/journal.pone.0229186. PubMed DOI PMC

Pöss J., Köster J., Fuernau G., Eitel I., De Waha S., Ouarrak T., Lassus J., Harjola V.-P., Zeymer U., Thiele H., et al. Risk stratification for patients in cardiogenic shock after acute myocardial infarction. J. Am. Coll. Cardiol. 2017;69:1913–1920. doi: 10.1016/j.jacc.2017.02.027. PubMed DOI